0,804  0,010  Caspase 9 stimulant
0,712  0,019  Transcription factor NF kappa B inhibitor
0,712  0,029  Apoptosis agonist
0,691  0,019  Antineoplastic (lung cancer)
0,654  0,011  Mutagenic
0,640  0,029  Antineoplastic (breast cancer)
0,611  0,012  Antineoplastic (melanoma)
0,619  0,027  CYP3A4 substrate
0,602  0,025  TNF expression inhibitor
0,580  0,005  Genotoxic
0,575  0,011  Lipoxygenase inhibitor
0,572  0,015  Chemopreventive
0,558  0,003  Catenin beta inhibitor
0,563  0,010  Antiprotozoal (Leishmania)
0,563  0,016  12-Lipoxygenase inhibitor
0,565  0,019  Antineoplastic (ovarian cancer)
0,559  0,013  Caspase 3 stimulant
0,549  0,005  Antineoplastic (squamous cell carcinoma)
0,557  0,014  Antioxidant
0,555  0,021  Antihypercholesterolemic
0,536  0,008  Antihypertriglyceridemic
0,534  0,011  DNA damaging
0,545  0,032  Antileukemic
0,531  0,022  Bone diseases treatment
0,524  0,016  Antineoplastic (brain cancer)
0,529  0,021  Carcinogenic
0,527  0,020  Sensitization
0,524  0,020  Antineoplastic (cervical cancer)
0,507  0,008  P-glycoprotein inhibitor
0,494  0,009  Antineoplastic (carcinoma)
0,498  0,016  Free radical scavenger
0,514  0,033  Antineoplastic (colorectal cancer)
0,508  0,032  Antineoplastic (colon cancer)
0,498  0,029  Histamine release inhibitor
0,481  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,478  0,021  NOS2 expression inhibitor
0,469  0,018  Hypoglycemic
0,470  0,024  Antiosteoporotic
0,477  0,041  CYP2C9 substrate
0,465  0,029  Cytotoxic
0,463  0,027  Cardioprotectant
0,459  0,025  Cytostatic
0,478  0,047  Antibacterial
0,450  0,023  Vasodilator, coronary
0,458  0,035  5 Hydroxytryptamine release stimulant
0,446  0,032  Hepatic disorders treatment
0,423  0,011  Hepatoprotectant
0,441  0,032  CYP1A2 substrate
0,427  0,025  Proliferative diseases treatment
0,416  0,020  Vasodilator
0,415  0,024  Antineoplastic (lymphoma)
0,398  0,010  Topoisomerase II inhibitor
0,414  0,030  Antineoplastic (non-small cell lung cancer)
0,431  0,047  CYP2C19 inhibitor
0,418  0,035  AR expression inhibitor
0,387  0,010  Bone formation stimulant
0,395  0,020  Antineoplastic (small cell lung cancer)
0,410  0,036  Lipoprotein disorders treatment
0,433  0,060  Calcium channel L-type activator
0,394  0,022  DNA synthesis inhibitor
0,406  0,034  UGT1A9 substrate
0,417  0,051  Ulceration
0,372  0,009  Alkylator
0,384  0,025  Antineoplastic (osteosarcoma)
0,399  0,040  Spasmolytic
0,388  0,031  Radiosensitizer
0,389  0,034  CYP1A2 inhibitor
0,377  0,028  Nitric oxide antagonist
0,378  0,029  Hypolipemic
0,398  0,052  Prostate cancer treatment
0,388  0,049  Antifungal
0,370  0,042  Antineoplastic (glioma)
0,337  0,011  Neurotrophic factor enhancer
0,429  0,103  Alpha-glucosidase inhibitor
0,353  0,032  Antimitotic
0,366  0,052  Respiratory analeptic
0,358  0,050  Teratogen
0,316  0,010  Topoisomerase I inhibitor
0,341  0,036  Vascular (periferal) disease treatment
0,336  0,041  Cardiodepressant
0,376  0,085  15-Lipoxygenase inhibitor
0,344  0,053  Antineoplastic (pancreatic cancer)
0,370  0,080  Antipruritic, allergic
0,329  0,040  Antineoplastic (glioblastoma multiforme)
0,300  0,013  Antiviral (Hepatitis B)
0,305  0,022  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,363  0,080  Immunosuppressant
0,341  0,058  Antiischemic
0,382  0,101  Cyclophilin D inhibitor
0,382  0,101  Antidiabetic
0,308  0,030  RNA-directed DNA polymerase inhibitor
0,318  0,044  Antineoplastic (liver cancer)
0,347  0,073  Antiprotozoal (Plasmodium)
0,360  0,087  Antiprotozoal
0,293  0,024  Antiseptic
0,318  0,055  Embryotoxic
0,273  0,012  Antineoplastic antibiotic
0,302  0,042  Antineoplastic (lymphocytic leukemia)
0,270  0,013  Cystathionine beta-synthase inhibitor
0,307  0,050  Tumour necrosis factor alpha release inhibitor
0,304  0,050  Antineoplastic (renal cancer)
0,275  0,022  Tubulin antagonist
0,289  0,037  Platelet adhesion inhibitor
0,304  0,059  Antihypoxic
0,303  0,060  UGT2B4 substrate
0,317  0,075  Apoptosis antagonist
0,251  0,010  Topoisomerase II alpha inhibitor
0,251  0,013  Carcinogenic, group 2B
0,303  0,066  Radioprotector
0,265  0,031  Mcl-1 antagonist
0,262  0,028  Protein-tyrosine phosphatase inhibitor
0,259  0,027  Melanin inhibitor
0,304  0,073  Analeptic
0,291  0,061  Chemoprotective
0,278  0,050  UGT1A6 substrate
0,254  0,027  Amylase inhibitor
0,253  0,026  Lipid peroxidase inhibitor
0,254  0,030  UGT1A3 substrate
0,264  0,043  Abortion inducer
0,264  0,044  UDP-glucuronosyltransferase substrate
0,258  0,039  UGT2B7 substrate
0,231  0,019  DNA intercalator
0,249  0,038  Dual specificity phosphatase inhibitor
0,261  0,055  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,228  0,023  Antifungal enhancer
0,256  0,052  Antiviral (HIV)
0,294  0,092  Antithrombotic
0,224  0,027  NADPH oxidase inhibitor
0,258  0,062  Antineoplastic (sarcoma)
0,305  0,112  CYP2C9 inhibitor
0,238  0,044  Dual specificity phosphatase 3 inhibitor
0,273  0,082  Antineoplastic (multiple myeloma)
0,235  0,044  Insulin sensitizer
0,241  0,052  VCAM1 expression inhibitor
0,354  0,170  Antiinflammatory
0,335  0,152  Antineoplastic (solid tumors)
0,189  0,010  HIV-1 integrase (Strand Transfer) inhibitor
0,233  0,054  UGT1A1 substrate
0,280  0,102  ICAM1 expression inhibitor
0,197  0,020  Cyclooxygenase 3 inhibitor
0,224  0,046  Antimutagenic
0,260  0,085  GST M1-1 substrate
0,252  0,077  Antineoplastic (bladder cancer)
0,280  0,105  Antineoplastic (endocrine cancer)
0,180  0,009  CDC25A inhibitor
0,194  0,023  Antibacterial (Helicobacter pylori)
0,261  0,099  CTGF expression inhibitor
0,203  0,041  UGT2B15 substrate
0,255  0,094  Immunostimulant
0,242  0,081  Antipyretic
0,219  0,062  Antiviral (Influenza)
0,198  0,044  Antiviral (Influenza A)
0,219  0,069  Amyloid beta aggregation inhibitor
0,188  0,039  Aldose reductase substrate
0,185  0,037  Monophenol monooxygenase inhibitor
0,156  0,008  Thioredoxin reductase inhibitor
0,180  0,035  Protein-tyrosine phosphatase 1B inhibitor
0,249  0,104  NOS3 expression inhibitor
0,170  0,029  Microtubule formation inhibitor
0,161  0,020  Breast cancer-resistant protein inhibitor
0,171  0,031  5-Lipoxygenase inhibitor
0,171  0,033  Antihemorrhagic
0,150  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,188  0,052  Antiviral (Herpes)
0,253  0,118  Antihypertensive
0,225  0,091  Antidiabetic symptomatic
0,155  0,026  Antineoplastic alkaloid
0,169  0,040  Toll-Like receptor 2 antagonist
0,211  0,086  Cyclic AMP phosphodiesterase inhibitor
0,239  0,117  Antimycobacterial
0,163  0,041  Antihyperlipoproteinemic
0,204  0,082  Nitric-oxide synthase stimulant
0,128  0,009  Neuraminidase inhibitor
0,150  0,030  HDL-cholesterol increasing
0,194  0,076  Non-steroidal antiinflammatory agent
0,157  0,044  Interleukin 4 antagonist
0,139  0,028  Electron transport complex I inhibitor
0,166  0,057  Protein kinase stimulant
0,138  0,030  Estrogen antagonist
0,157  0,050  Skin whitener
0,130  0,023  Estrogen receptor beta antagonist
0,116  0,013  Neuraminidase (influenza) inhibitor
0,150  0,047  Cell adhesion inhibitor
0,224  0,122  CYP2D6 substrate
0,118  0,016  HIV-1 integrase inhibitor
0,121  0,020  Peroxisome proliferator-activated receptor gamma agonist
0,132  0,033  Toll-Like receptor 4 antagonist
0,114  0,015  Aldose reductase inhibitor
0,152  0,054  Psychosexual dysfunction treatment
0,192  0,095  Antiulcerative
0,131  0,034  DOPA decarboxylase inhibitor
0,137  0,041  Chelator
0,197  0,102  Platelet antagonist
0,140  0,046  Antineoplastic (uterine cancer)
0,159  0,066  Acaricide
0,166  0,074  UGT2B10 substrate
0,141  0,050  Skin irritative effect
0,113  0,025  ATPase (Vacuolar H+) inhibitor
0,137  0,049  Papain-like protease (SARS coronavirus) inhibitor
0,153  0,069  Antidote
0,190  0,110  Aldehyde oxidase inhibitor
0,152  0,072  Heat shock protein 90 antagonist
0,102  0,025  Leukotriene synthesis inhibitor
0,120  0,044  CDC-like kinase 3 inhibitor
0,082  0,008  Antiviral (Hepatitis D)
0,120  0,047  Xanthine oxidase inhibitor
0,105  0,032  Antibiotic
0,150  0,079  Eye irritation, high
0,182  0,110  Antiglaucomic
0,093  0,021  Antitreponemal
0,220  0,148  CYP3A4 inhibitor
0,092  0,021  Prostaglandin EP2 antagonist
0,103  0,033  Macrophage migration inhibitory factor inhibitor
0,120  0,051  Expectorant
0,087  0,018  Alpha tubulin antagonist
0,161  0,094  Antineoplastic (bone cancer)
0,125  0,058  Alcohol dehydrogenase substrate
0,096  0,030  Lipase inhibitor
0,156  0,092  Myocardial ischemia treatment
0,226  0,165  Stroke treatment
0,085  0,024  CDC25B inhibitor
0,130  0,070  Acetylcholinesterase inhibitor
0,118  0,058  SULT1A1 substrate
0,160  0,101  Antiviral (Hepatitis)
0,196  0,136  CYP2C19 substrate
0,104  0,045  ABCA1 expression enhancer
0,101  0,047  Thioredoxin inhibitor
0,110  0,058  Mediator release inhibitor
0,217  0,165  Sodium/bile acid cotransporter inhibitor
0,075  0,024  Estrogen agonist
0,083  0,033  Elastase 1 inhibitor
0,076  0,026  Nitric oxide donor
0,170  0,121  Antineoplastic enhancer
0,098  0,051  SULT1E1 substrate
0,108  0,062  Glutathione S-transferase substrate
0,150  0,105  Antineoplastic (gastric cancer)
0,112  0,068  Photosensitizer
0,073  0,030  Antidote, heavy metal
0,184  0,142  Antituberculosic
0,176  0,135  Peptidyltransferase inhibitor
0,155  0,115  Antirickettsial
0,089  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,189  0,150  Transcription factor STAT3 inhibitor
0,052  0,014  Squalene synthetase inhibitor
0,081  0,043  Glutamate decarboxylase inhibitor
0,081  0,047  Keratolytic
0,131  0,101  UGT1A4 substrate
0,066  0,036  Beta tubulin antagonist
0,252  0,225  5 Hydroxytryptamine release inhibitor
0,063  0,036  Heat shock protein 90 beta antagonist
0,079  0,052  NAD(P)H dehydrogenase (quinone) inhibitor
0,039  0,013  Endothelin receptor antagonist
0,033  0,008  Endothelin B receptor antagonist
0,052  0,030  Topoisomerase II beta inhibitor
0,100  0,079  Multidrug resistance-associated protein 1 inhibitor
0,092  0,073  Sulfotransferase substrate
0,097  0,078  Choleretic
0,102  0,084  Carcinogenic, group 3
0,081  0,066  Transcription factor NF kappa B stimulant
0,211  0,197  Calcium channel activator
0,104  0,091  Aldehyde dehydrogenase inhibitor
0,128  0,115  Interferon gamma antagonist
0,120  0,107  SULT1A3 substrate
0,199  0,187  GST A substrate
0,095  0,085  Mucolytic
0,130  0,123  Carcinogenic, group 1
0,074  0,066  Carbonic anhydrase VI inhibitor
0,021  0,015  Endothelin A receptor antagonist
0,047  0,043  Factor III inhibitor
0,057  0,054  Leukotriene antagonist
0,101  0,099  Cyclooxygenase 1 inhibitor
0,086  0,085  UGT2B11 substrate
0,089  0,088  UGT2B1 substrate
0,176  0,176  Prostaglandin dehydrogenase inhibitor
0,170  0,170  Antidiabetic (type 2)

